Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
21.59
-0.30 (-1.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Stevanato Group Employees
Stevanato Group had 5,521 employees as of December 31, 2024. The number of employees decreased by 114 or -2.02% compared to the previous year.
Employees
5,521
Change (1Y)
-114
Growth (1Y)
-2.02%
Revenue / Employee
$207,030
Profits / Employee
$22,086
Market Cap
5.89B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
STVN News
- 3 days ago - Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 6 weeks ago - Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - Business Wire
- 7 weeks ago - Stevanato: Ramping Syringe Demand, Buy Confirmed - Seeking Alpha
- 7 weeks ago - Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024 - Business Wire
- 2 months ago - Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025 - Business Wire
- 3 months ago - Stevanato Group to Present at Upcoming Investor Conference - Business Wire
- 5 months ago - Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha